News & Updates
Filter by Specialty:
Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery
Apixaban is not inferior to enoxaparin for extended-duration venous thromboembolic event (VTE) prophylaxis (EP) following urologic oncology surgery, reveals a study. In addition, apixaban is associated with fewer major complications and compliance-related adverse events.
Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery
29 Sep 2022Renal denervation bounces back in 3-year follow-up study
Following negative primary results, the final follow-up of the SYMPLICITY HTN-3 trial takes a turn for the better, demonstrating significant blood pressure (BP) reductions with renal denervation (RDN) in patients with uncontrolled hypertension (HTN).
Renal denervation bounces back in 3-year follow-up study
29 Sep 2022Molnupiravir and nirmatrelvir/ritonavir show favourable hepatic safety in COVID-19 patients in HK
A territory-wide cohort study in Hong Kong shows favourable hepatic safety profile with the oral antivirals, molnupiravir and nirmatrelvir/ritonavir, in COVID-19 patients, including those at risk of drug-induced liver injury (DILI).
Molnupiravir and nirmatrelvir/ritonavir show favourable hepatic safety in COVID-19 patients in HK
29 Sep 2022New ROTA imaging technique improves early diagnosis of glaucoma
Researchers from the University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK) have jointly developed an advanced imaging technique for retinal nerve fibre layer optical texture analysis (ROTA) that can improve the detection of early optic nerve damage in glaucoma.
New ROTA imaging technique improves early diagnosis of glaucoma
29 Sep 2022Telepsychiatry as reliable as face-to-face interviews for symptom assessment
Assessments of depressive, anxiety and psychotic symptoms and suicidal risk by telepsychiatry have good reliability in general when compared with face-to-face interviews, according to researchers from the Queen Mary Hospital (QMH).